NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G. Mazzini”, Asl 4
Department of Neurosciences and Imaging, Chair of Psychiatry, University “G. d’Annunzio” of Chieti, Italy
Domenico De Berardis holds both the Ph.D. and M.D. degrees. He works as Psychiatrist in the "real world" clinical practice at the NHS Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital “G. Mazzini”, ASL 4 Teramo, Italy and collaborates independently with the Institute of Psychiatry of G. d’Annunzio University Chieti-Pescara, Italy. He is specialized in Medicina delle Farmacotossicodipendenze, has attained a Ph.D. in Functional Neuroimaging at the Institute for Advanced Biomedical Technologies (ITAB) of the University G. D'Annunzio of Chieti and has a master in Clinical Psychopharmacology obtained at the University Vita-Salute San Raffaele of Milano. He has also achieved a master in Healthcare Communication in 2013 at University of Teramo. He is specialized in Cognitive-Behavioral Therapy (CBT) and works also as psychotherapist mainly treating patients with personality disorders and OCD. He is the principal investigator of several research projects, mostly related to alexithymia, anxiety disorders, suicide, schizophrenia, neuroimaging, and clinical psychopharmacology. He has published over 120 articles with impact factor, for an h-index of 39 (Google Scholar, 2019) and 31 (Scopus, 2019), and has frequently participated in national and international congresses as a speaker or through oral or written communications. These papers together with several book chapters reflect his main research lines and areas of recognized expertise on alexithymia, anxiety and mood disorders, functional magnetic resonance and clinical psychopharmacology. He regularly collaborates with professors and researchers from other universities in Italy and other European as well as US and Indian countries. His professional activities also include the reviewing of scientific manuscripts for high-impact journals and is a member of the Editorial Board of Journal of Clinical Medicine, Diseases, Current Drug Therapy, Current Drug Discovery Technologies, Current Psychopharmacology, The Open Biology Journal, ISRN Psychiatry, Annals of Depression and Anxiety, International Journal of Clinical Toxicology, Journal of Psychology and Psychotherapy Research, Bipolar Disorder: Open Access, Journal of Neuropsychopharmacology and Mental Health, Journal of Advanced Biomarkers Research and Journal of Sleep Medicine and Disorders. He is Associate Editor of Research and Advances in Psychiatry and Academic Editor of British Journal of Medicine and Medical Research. He serves also as Review Editor in the field of Neurodegeneration and Addictive Disorders for Frontiers in Neuroscience (IF 3.398), Frontiers in Psychiatry and Frontiers in Neurology (IF 3.184).